The global smart stethoscope market size is estimated to reach USD 90.1 million by 2030, expanding at a CAGR of 7.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. A surge in the geriatric population, high adoption of technologically advanced products, growing healthcare infrastructure, and various government initiatives are the key driving factors for the market.
The smart stethoscope is user-friendly and cost-effective equipment that assists physicians in obtaining reliable results. Based on heart rate, these stethoscopes help in the diagnosis of respiratory diseases and disorders. Until now, the traditional stethoscope has played a significant role in the department of cardiology. Though, the medical device has some disadvantages, such as poor sound quality, which is particularly noticeable in obese patients and those with a thick chest wall. Hence, there is a booming demand for advanced stethoscopes to replace the traditional version of the medical, leading to market growth.
High prevalence of cardiovascular disorders, enhanced diagnosis, are other factors driving the market. As projected by the WHO, heart disease is the leading cause of death in the U.S., causing around 647,000 deaths every year. Technological advances, as well as the continuous introduction of new and innovative products, are key drivers of business expansion. For instance, recently in July 2020, HD Medical received FDA clearance for its HD Steth that uses artificial intelligence to aid clinicians to perform an advanced cardiac assessment at point-of-care.
Auscultation of the chest is important in COVID-19 patients, particularly those with poor respiratory conditions such as serious pneumonia and respiratory dysfunction, as well as intensive cases who are anesthetized and whose breathing is supported by a ventilator. Nevertheless, proper auscultation of these patients is challenging when medical staff wears personal protective equipment and when communicating with patients is restricted. In such cases, smart stethoscopes are witnessing a major upswing in popularity and novelty.
Request a free sample copy or view report summary: Smart Stethoscope Market Report
In terms of application, the cardiovascular segment held the largest revenue share of 28.9% in 2023 owing to the increasing prevalence of heart diseases
In terms of end-use, the hospitals segment held the largest revenue share in 2023. The segment growth is majorly driven by the increasing number prevalence of cardiac and lung disorders
In Asia Pacific, the market is anticipated to register the fastest CAGR over the forecast period owing to the rising aging population and presence of huge untapped potential
Grand View Research has segmented the global smart stethoscope market based on application, distribution channel, end use, and region:
Smart Stethoscope Application Outlook (Revenue, USD Million, 2018 - 2030)
Cardiovascular
Neonatal
Pediatric
Fetal
Teaching
Others
Smart Stethoscope Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Distributors
E-commerce
Direct Purchase
Smart Stethoscope End Use Outlook (Revenue, USD Million, 2018 - 2030)
Home Healthcare
Hospitals
Clinics (Individual Clinics)
Nurse Practitioners
EMT/ First Responders
Veterinary
Smart Stethoscope Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Kuwait
List of Key Players in Smart Stethoscope Market
3M
Thinklabs Medical LLC
HD Medical, Inc.
Eko Health, Inc.
eKuore
M3DICINE Pty Ltd.
Sonavi Labs
Steth IO
Medline Industries
"The quality of research they have done for us has been excellent..."